自组装DNA纳米载体支持的药物输送用于骨改造和抗菌应用
Jiaqi Huang1, Aishik Chakraborty1,2, Yasmeen Shamiya3
1Department of Chemical and Biochemical Engineering, The University of Western Ontario, London, ON N6A 5B9 Canada.
NPJ biomedical innovations
|September 8, 2025
概括
合成四面体DNA纳米载体显示出治疗骨缺陷和MRSA感染的前景. 这些纳米载体增强了用于骨改造和抗击细菌的药物输送,为骨折和手术部位感染提供了潜在的解决方案.
科学领域:
- 生物技术是生物技术.
- 材料科学 材料科学 材料科学
- 纳米医学是一种纳米医学.
背景情况:
- 骨缺陷和感染,如耐美西林黄金葡萄球菌 (MRSA),带来了重大的临床挑战.
- 目前的治疗方法可能在有效性或向性治疗方面存在局限性.
研究的目的:
- 合成和评估一种新的四面体DNA纳米载体 (TDN),用于联合输送治疗剂.
- 评估TDN在体外治疗骨缺陷和MRSA感染方面的潜力.
主要方法:
- 四面体DNA纳米载体 (TDN) 的合成.
- 在体外评估TDN与血液和免疫细胞的细胞相容性.
- 装载TDNs与骨改造的zoledronic酸和抗菌活性的万科米辛.
- 在体外对药物载入的TDN疗效的评估.
主要成果:
- 成功合成了具有出色细胞相容性的TDNs.
- 与免费药物相比,装载着zoledronic酸的TDNs证明了骨重塑调节的增强.
- 载有万科素的TDN对MRSA的抗菌作用增加.
- 纳米载体平台显示了多功能治疗潜力.
结论:
- 四面体DNA纳米载体代表了针对骨再生和感染治疗的向药物输送的可行平台.
- TDNs为治疗骨缺陷和MRSA感染提供了一种有希望的方法,有可能改善患者的治疗结果.
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...